Undervalued Stocks Based On Cash Flows

Results

29

6 new

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

29 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
6990
New
HK$435.6011.0%33.1%HK$101.6bHK$547.6442.844.8%n/aPharmaceuticals & Biotech
1364
New
HK$21.022.8%-17.7%HK$50.0bHK$33.7513.914.5%2.4%Consumer Services
1318
HK$54.00-0.9%-50.1%HK$26.5bHK$104.0919.117.2%2.1%Household
9660
New
HK$4.14-0.2%-36.2%HK$60.3bHK$11.1613.976.7%n/aSoftware
2190
HK$18.532.4%-10.9%HK$6.2bHK$30.3122.025.4%1.4%Healthcare
6656
HK$363.80-7.7%n/aHK$89.8bHK$650.2026.733.1%n/aCapital Goods
2698
HK$25.56-4.8%n/aHK$15.8bHK$40.5116.714.9%2.7%Household
1768
HK$302.60-6.9%n/aHK$65.9bHK$508.5824.523.9%n/aConsumer Retailing
2315
New
HK$46.8812.5%108.4%HK$48.0bHK$62.0262.540.4%n/aPharmaceuticals & Biotech
1801
HK$80.056.2%2.1%HK$139.1bHK$117.58148.231.1%n/aPharmaceuticals & Biotech
2338
HK$33.72-17.8%111.5%HK$268.4bHK$45.3322.421.5%2.5%Capital Goods
1180
New
HK$0.7811.4%6.8%HK$820.7mHK$1.3075.179.9%12.8%Consumer Services
9926
HK$91.6510.5%-0.3%HK$84.4bHK$169.1723.946.6%n/aPharmaceuticals & Biotech
1357
HK$3.78-7.8%-58.1%HK$17.2bHK$9.3220.331.4%2.6%Media
9658
HK$9.48-4.7%-38.5%HK$6.2bHK$14.4527.530.5%n/aConsumer Services
1060
HK$0.47-8.8%-51.6%HK$13.9bHK$0.9417.120.4%n/aMedia
2487
HK$2.79-11.1%-72.2%HK$1.0bHK$11.282.699.3%n/aPharmaceuticals & Biotech
2252
HK$23.521.8%45.5%HK$24.3bHK$37.5138.190.1%n/aHealthcare
2145
HK$28.22-3.9%-65.6%HK$11.2bHK$85.968.816.7%5.1%Household
2420
HK$3.920%21.0%HK$2.0bHK$6.786.322.7%5.8%Retail
2589
HK$121.60-11.0%-8.3%HK$12.8bHK$88.3522.114.3%1.9%Consumer Services
2235
HK$7.12-0.8%20.3%HK$3.0bHK$11.8163.944.9%n/aHealthcare
23
HK$12.76-1.5%5.5%HK$33.7bHK$14.260.325.9%4.8%Banks
2268
HK$58.3021.1%40.1%HK$73.5bHK$84.5143.025.3%n/aPharmaceuticals & Biotech
Page 1 of 1